The Bcl-2 family of proteins has been characterized by either anti-apoptotic or pro-apoptotic activity. Insight into how Bcl-2 family members function has been gained by determining their intracellular localization. We have generated a monoclonal anti-A1-a antibody and used a COS-7 overexpression system to study the localization of the murine anti-apoptotic Bcl-2 family member, A1-a. A1-a overexpressed in COS-7 cells localized to the nucleus as determined by subcellular fractionation and immunofluorescent microscopy. A1-a in the COS-7 nucleus bound tightly to the nuclear matrix as evidenced by resistance to treatment with DNAse I and RNAse A and sequential extraction with 1.0% Triton X-100, 0.15 M NaCl, 0.25 M HCl, 0.5 M Tris pH 7.4 and 6 M urea. HPLC analysis of A1-a, subsequent to SDS extraction, produced fractions that gave multiple bands when analyzed by Western blot analysis suggesting a propensity to form multimers. COS-7 cells transfected with A1-a were protected from apoptotic induction by staurosporine treatment. Cell Death and Differentiation (2001) 8, 785 ± 793.
Introduction
The Bcl-2 family of proteins are important mediators of apoptosis. Bcl-2 was the first of the anti-apoptotic proteins to be cloned. 1, 2 It was initially discovered as a proto-oncogene that did not promote cell proliferation, but instead promoted cell survival. 3 While the Bcl-2 related protein CED-9 is the only protein of its kind in C. Elegans, 4 mammalian cells have evolved a family of Bcl-2 like proteins with both pro-apoptotic activities, including Bax, Bad, Bid, Bcl-X S and Bak, and antiapoptotic capacity including Bcl-2, Bcl-X L , Mcl-1, Bcl-w and A1-a (reviewed in 5 ± 8 ). The logic of evolving multiple proteins within a family may be explained by the expression of these proteins. Numerous studies have shown that whereas multiple Bcl-2 family members may be expressed in a specific cell type and a particular state of cellular differentiation, many of the Bcl-2 family members also differ in their expression pattern allowing for tissue-specific, differentiationspecific and external stimuli-specific expression and regulation. 9 ± 15 In the quest to elucidate the mechanism of action of the Bcl-2 family, numerous studies have focused on determining the subcellular localization of these proteins. Bcl-2 family members can localize to various sites within the cell and different members can be found differentially localized within the same cell type. 13,15 ± 25 Localization can be important in Bcl-2 family member function. Mitochondrial Bcl-2 prevents the release of Cytochrome c, thus blocking Cytochrome c-dependent APAF-1 activation of the caspase cascade leading to apoptosis. 26 ± 29 Mutants that abrogate known localization also impede function during apoptosis. 22,30 ± 33 For example, in transiently transfected COS-7 cells, Bcl-2 localizes to the membrane fraction, while Bax is found in the cytosol. Under staurosporine treatment to induce apoptosis, Bax translocates to the mitochondria. Mutations in Bax that block this movement also abrogate apoptosis-promoting activity. 23 A1-a is a Bcl-2 family member found primarily in hematopoietic cells. 9 Initial studies have shown that A1-a can protect cells from undergoing apoptosis in a manner similar to Bcl-2. 34 When 32Dcl3 myeloid precursor cells were induced to undergo apoptosis by growth factor withdrawal, stable transfection with either A1-a or Bcl-2 protected equally against death. Co-transfection with both A1-a and Bcl-2 conferred greater protection than either protein alone, suggesting differences in their mechanism of action. 34 When 32Dcl3 cells undergo interleukin 3 withdrawal, a small population undergoes spontaneous neutrophilic differentiation. In the stable transfectants, A1-a was permissive for spontaneous differentiation, while Bcl-2 blocked spontaneous differentiation.
We generated a monoclonal antibody against A1-a in order to determine its subcellular localization. Previous studies in our laboratory have shown that A1-a localizes to the cytoplasm in primary inflammatory macrophages, but can also be found in the nucleus in a fraction of apoptotic cells. 35 This study shows that transient overexpression of A1-a in COS-7 cells results solely in nuclear localization as determined by both Western blot analysis and immunofluorescent microscopy. Use of a COS-7 cell overexpression system produced sufficient A1-a to permit biochemical analysis of the extractability of A1-a from the nucleus. While minimal A1-a was extracted with the nuclear membrane fraction, the majority resisted extraction suggesting A1-a could be associated with the nuclear matrix. A1-a was also found to protect COS-7 cells against staurosporine induced apoptosis. These results suggest A1-a is a Bcl-2 family member with a unique localization and that nuclear-localized A1-a is associated with an antiapoptotic effect.
Results
Generation of A1-a speci®c monoclonal antibody 20.5
Rats were immunized with partially purified A1-a produced using a prokaryotic expression system and sera were screened using an A1-a ELISA employing A1-a produced with a mammalian expression system. Once a rat with positive serum for anti-A1-a antibody was detected, hybridomas were produced and screened using the mammalian A1-a ELISA. A positive clone, 20.5, was chosen and assayed by Western blot analysis. The monoclonal antibody 20.5 recognizes murine A1-a expressed in transiently transfected COS-7 cells and does not detect proteins in extracts of COS-7 cells transiently transfected with an empty vector ( Figure 1 ). While the COS-7 cell produced A1-a migrates around 17 KD, mass spectrophotometry revealed the protein to be 21 KD as predicted by amino acid sequence analysis (data not shown) suggesting A1-a migrated ahead of the markers and was not digested to a smaller form. Figure 1 Western blot analysis of A1-a specific antibody. COS-7 cells were transfected with either A1-a or empty vector (mock). Cells were harvested at day 5 after transfection to make whole cell lysates. The lysates were run on a 15% SDS polyacrylamide gel, which was then transferred to a PVDF membrane. The blots were probed initially with sera from A1-a inoculated rats and one positive rat was selected to create a hybridoma culture. Hybridoma clones were screened for anti-A1-a antibody activity and one successful clone was chosen for future experiments. Monoclonal antibody 20.5 recognizes a band in the A1-a transfected COS-7 lysate lane but not in the empty vector (mock) lane showing the specificity to A1-a by the antibody Figure 2 A1-a is found in the nuclear fraction of transfected COS-7 cells by Western blot analysis. COS-7 cells were transfected with an A1-a overexpression vector and harvested on days 3, 4, 5, 6 and 7 after transfection. Cells were harvested and made into whole cell lysates. A portion of each lysate was separated into a nuclear and cytoplasmic fraction (see Materials and Methods). The whole cell lysate, nuclear and cytoplasmic fractions were separated on a 15% SDS polyacrylamide gel and subsequently transferred to a PVDF membrane. 
A1-a localizes to the nucleus of transfected COS-7 cells
Bcl-2 is known to localize to intracellular membranes including mitochondrial, endoplasmic reticular and nuclear membranes. 16 ± 19 To determine if the subcellular distribution of A1-a is similar to Bcl-2, COS-7 cells were transfected with A1-a, harvested by trypsinization, fractionated into nuclear and cytoplasmic fractions and solubilized with Laemmeli buffer 5 days after transfection. The fractions were subjected to Western blot analysis with the A1-a monoclonal antibody. A1-a was found to be exclusively nuclear (Figure 2A) . Fractions prepared at days 3, 4, 6 and 7 after transfection also showed exclusively nuclear localization (data not shown). To verify proper subcellular fractionation, the COS-7 A1-a whole cell, nuclear and cytoplasmic fractions were probed for Cytochrome c, an endogenous mitochondria marker. Cytochrome c was found exclusively in the cytoplasmic fraction ( Figure 2B ) indicating that nuclear localization of A1-a did not result from contamination of the nuclear fraction by cytoplasmic proteins.
Immunofluorescence microscopy was used to determine if A1-a localized to the nuclear membrane or the entire nucleus. COS-7 cells were grown in chamber slides and 5 days after transfection with A1-a were analyzed using monoclonal antibody 20.5. A1-a was found to localize in the nucleus as detected by confocal microscopy ( Figure 3A ± D). Cells were counterstained for actin to visualize the cytoplasmic portion of the cell. Cells transfected with the empty vector did not stain with the anti-A1-a antibody (data not shown). As with the Western blot analysis, nuclear A1-a was detectable 1 day after transfection and maximal by 3 days. A1-a in 1 or 2 day transfectants showed either punctate nuclear staining or staining in the nuclear periphery (data not shown). To determine if A1-a localization in the nucleus is an artifact due to overexpression or expression in an atypical cell line, Bcl-2 was also overexpressed in COS-7 cells and examined by confocal microscopy. Bcl-2 in transfected COS-7 cells appears to localize to membranes and mitochondria (Figure 3E ± F) which is consistent with previous findings, suggesting that nuclear localization is specific for A1-a in COS-7 cells.
A1-a is tightly bound in the nucleus of transfected COS-7 cells
In order to determine the sublocalization of A1-a in the nucleus, the nuclear fraction of A1-a transfected COS-7 cells was subjected to a treatment with DNAse I and RNAse A. This procedure failed to release A1-a from the nuclear fraction (data not shown). The nuclear fraction of A1-a transfected COS-7 cells was then subjected to a sequential extraction protocol. The nuclear pellet was washed twice with 1% Triton-X100, to remove integral membrane proteins, 36 ± 38 followed by 0.15 M NaCl, which removes peripheral membrane 36, 38 and finally solubilized in a Laemmli buffer containing 2% SDS. The supernatant of each wash and the SDS solubilized pellet were separated using 15% SDS ± PAGE and either stained with coomassie blue or analyzed by Western analysis. The coomassie stained gel shows a prominent band co-migrating with A1-a in the SDS solubilized pellet ( Figure 4A ). It is conceivable that the concentrating effects of the sequential extraction protocol enriched for A1-a sufficiently to visualize an A1-a band by coomassie staining. Western blot analysis confirms the presence of A1-a in the SDS solubilized pellet ( Figure 4B ) suggesting that A1-a is associated with the nuclear matrix. A small amount of A1-a is present in each of the Triton-X100 wash lanes suggesting some A1-a may also be membrane bound. Lane 7 also shows several bands migrating more slowly than the A1-a monomer. At least some of these bands are present in the whole extract ( Figure 2A ). They may represent both homo-and heteromultimers of A1-a and their presence indicates that sequential extraction enriches for both monomers and multimers. Slower migrating forms not found in the whole cell extract may be an artifact of the extraction procedure or minor species not appreciated in the whole cell extract.
HPLC analysis of nuclear A1-a suggests a tendency for multimerization
After performing the extractions above, the final pellet resuspended in SDS sample buffer was precipitated with acetone and resolubilized in 6 M urea. This sample was analyzed by reversed-phase HPLC and proteins were eluted with increasing concentrations of acetonitrile. All peaks with absorbance at 210 nm were analyzed by Western blot analysis ( Figure 5A ). Only fractions A, B & C contained detectable A1-a ( Figure 5A inset) . Western blot analysis from another HPLC separation comparing the HPLC purified fractions with the material loaded onto the column ( Figure  5B ) shows a major A1-a monomer band and multiple minor bands representing A1-a multimers. The estimated size of the multimers suggests that some of them are A1-a homomultimers. As multimerization remains throughout HPLC separation, this suggests A1-a has a strong proclivity to multimerize. Which of these species are homomultimers or heteromultimers has yet to be determined.
Nuclear A1-a protects COS-7 cells from staurosporine induced apoptosis
As nuclear A1 has been observed in apoptotic cells, 35 both A1-a and empty vector transfected cells were assayed by TUNEL to determine if nuclear A1-a correlated with apoptosis in COS-7 cells. Both A1-a and empty vector transfectants had an equal percentage of TUNEL positive cells, ranging from 1 ± 7%, in three independent experiments. This suggests that A1-a does not induce apoptosis in COS-7 cells. In addition, A1-a transfected COS-7 cells were stained for both A1-a and TUNEL and the few apoptotic cells present were all negative for A1-a (data not shown) suggesting an inverse association between A1-a positive nuclei and apoptosis in this system. In order to determine if nuclear A1-a does protect against apoptosis, COS-7 cells were transfected with either A1-a or empty vector. Three days after transfection, cells were treated with 3 mM staurosporine for up to 6 h. Cells were then harvested each hour for immunofluorescent microscopy and probed for the presence of A1-a as well as apoptosis ( Figure   Figure 4 A1-a remains with the nuclear fraction through a series of extractions. Nuclear fractions were made from COS-7 cells transfected with A1-a. The nuclear fraction was then subjected to a sequential series of extractions. Specifically, nuclei were subjected to two sets of washes with 1% triton-X100 (lanes 1 and 2), followed by 0. 6A ± E). Over 300 COS-7 cells were counted on each slide for each timepoint in two separate experiments. COS-7 cells were found to be transfected with 30% efficiency. The amount of apoptosis found at each timepoint reached maximal levels at 4 h (Figure 7) . At 4 h, 47% of the mock transfected cells were TUNEL positive, as opposed to 15% among the A1-a transfected cells. The subsequent decrease in per cent TUNEL positivity among the mock transfected cells may be due to loss of cellularity caused by staurosporine-induced death. It is important to note that not a single TUNEL positive cell from the A1-a transfected population was A1-a positive ( Figure 7) indicating that A1-a protects COS-7 cells from apoptosis. In addition, staurosporine treatment was extended to 24 and 48 h when almost 100% of untransfected COS-7 cells were killed. At 24 h, the number of A1-a positive cells sharply decreased, even more so at 48 h, yet not a single A1-a positive cell was TUNEL positive at either time point (data not shown). This suggests that A1-a positive cells can die, but only after removal of A1-a.
Discussion
We have shown that murine A1-a can localize within the nucleus of COS-7 cells upon transient transfection with an A1-a expression vector. Previous studies in our laboratory have shown that nuclear A1-a occurs in some inflammatory leukocytes undergoing apoptosis. 35 By using a COS-7 overexpression system, we were able to examine nuclear localization more closely. By both biochemical and immunofluorescent analysis, A1-a was found to be exclusively nuclear, in contrast to our in vivo results which showed predominantly cytoplasmic localization. 35 Recently, two studies have shown that Bcl-2, Bax and Mcl-1 can display a mixed pattern of cytoplasmic and intranuclear localization. 24, 25 In contrast, we show that A1-a can adopt an exclusively intranuclear localization, even in a cell type in which Bcl-2 is restricted to the cytoplasm. A1-a does not have a known nuclear localization sequence. However, other nuclear proteins without nuclear localization sequences are known to be shuttled to the nucleus by escort proteins.
40
A1-a overexpressed in COS-7 cells appeared to distribute to the nuclear matrix. Extraction procedures that removed membrane proteins, pore proteins and DNA associated proteins did not extract A1-a, suggesting localization to the nuclear matrix. It has been shown that the viral Bcl-2 family member, E1B 19K, binds to lamins, which are found in the nuclear lamina underlying the inner nuclear membrane. Mutations that cause mislocalization of the lamins, and thus change the localization of E1B 19K protein, lead to abrogation of the E1B 19K anti-apoptotic activity. 41 A possible mechanism E1B 19K may use to block apoptosis may involve sequestration of pro-apoptotic proteins. The E1B 19K protein has been shown to sequester CED-4, the C. elegans APAF-1 homologue, from the cytosol to the nucleus, abrogating the ability of CED-4 to activate caspase-8. 42 The E1B 19K protein also blocks apoptotic induction by sequestering FADD, a mammalian caspase recruiting protein that functions in Fas mediated apoptosis. 43 E1B 19K can also confer protection by binding and sequestering Btf, a transcription factor that induces apoptosis upon overexpression. 44 Given the difficulty in extracting A1-a from the COS-7 nucleus and its tendency to multimerize, it would be easy to believe that A1-a might function in an anti-apoptotic manner via proteinprotein interaction. Further studies are needed to determine which proteins A1-a interacts with and if A1-a sequesters these proteins during apoptotic induction.
The ability to regulate transcription could be another possible mechanism in which A1-a could exert a protective effect. It has already been shown that Bcl-2 family members can regulate transcription. It is unclear if the Bcl-2-like proteins interact directly or indirectly with transcription factors, but in some cases, this form of association is associated with protection against apoptosis. 45 ± 51 The nuclear localization of A1-a would make the targeting of a transcription factor much easier and possibly through direct interaction. All together, these results show that different Bcl-2 family proteins can share and diverge in their methods of blocking apoptosis and that the difference in localization between A1-a and Bcl-2 may lead to differing mechanisms of protection. This is also suggested by data from our lab showing that A1-a and Bcl-2 co-transfectants have a greater survival effect than each protein alone in factor deprived 32Dcl3 cells. 34 In addition to the novel localization pattern of A1-a, we have also shown that A1-a expressing COS-7 cells are not apoptotic following exposure to staurosporine. While long term exposure (24 ± 48 h) to staurosporine caused most cells to die, only A1-a negative cells were found to die at any time after staurosporine treatment. Even though the percentage of A1-a positive cells declined over this treatment period, the A1-a positive cells did remain viable as determined by TUNEL staining. While previous findings from our lab have shown that only apoptotic cells could occasionally contain nuclear A1-a, 35 our results are not inconsistent with the previous finding. Previously, we have shown that A1-a was found in the nucleus of cells only when that cell was apoptotic. Those cells were activated inflammatory cells and could have multiple pathways for apoptotic induction, including one that is A1-a independent. The question remains how does A1-a exert its function from the nucleus. Since staurosporine is a protein kinase C inhibitor, it acts to induce apoptosis in the cytoplasm. If A1-a acts to sequester factors as some of its family members are known to do, it could easily sequester vital pro- 
Materials and Methods

Monoclonal antibody generation
Female LEW/CrlBr rats were immunized by i.p. injection of 100 mg of partially purified A1-a produced from a prokaryotic expression system. 34 Prior to injection, A1-a was conjugated to KLH (Pierce) and diluted in an equal volume of adjuvant (Ribi). Bleeds were examined for anti-A1-a activity by ELISA (see below). Rats with positive sera were given 100 mg of A1-a i.p. 3 days prior to sacrifice. At sacrifice, the spleen was removed and the hematopoietic cells isolated were fused with Ag8.653 myeloma cells 52 in a 4 : 1 ratio with polyethylene glycol as described before. 53 Successful fusions were selected using HAT medium. These cells were then cloned in soft agarose containing HAT medium at a concentration of 2000 cells/ml/ 60 mm plate. Clones were picked and grown to generate supernatant that was assayed for anti-A1-a antibody activity by ELISA.
Transfection and harvest of COS-7 cells
COS-7 cells were transfected by the DEAE-dextran method as described before. 54 Briefly, 20 h before transfection, cells were plated on 100 mm tissue culture dishes (Corning) at 1.8610 6 cells/dish in 10 ml of complete medium. After 20 h, the medium was aspirated and the cells washed once with 5 ml of PBS. Four milliliters of DMEM supplemented with 10% Nu-serum IV (Collaborative Research) was added to the plate. Ten mg of plasmid DNA containing the SV40 virus replication origin (either parent vector RJB10B 54 or RJB-A1-a 34 or pRC/CMV-Bcl2 55 ) in 0.2 ml of tris-buffered saline at pH 7.4 was mixed with 0.8 ml of serum free DMEM containing 1 mg/ml DEAE-dextran and 250 mM chloroquine and incubated with COS-7 cells at 378C for 4 h. The transfection solution was then aspirated and incubated with 5 ml of 10% DMSO in PBS for 4 min. After removing the DMSO, cells were washed once in 5 ml of PBS and incubated in 10 ml of complete medium until harvest. Five days post transfection, cells were harvested in one of three ways. First, COS-7 cell lysates were made by trypsinizing the cells from the plates, pelleting the cells by centrifugation and solubilizing the pellet in a modified Laemmli gel sample buffer. 34 Second, slides were made by lifting transfected cells from the tissue culture plate by trypsinization and seeding chamber slides (Lab-Tek) with 10 5 cells per chamber. The slides were then incubated at 378C overnight, fixed in cold paraformaldehyde (4% in PBS) for 15 min, washed three times in PBS and stored at 48C in PBS with 0.002% azide. Third, COS-7 cells were trypsinized and pelleted by centrifugation as above. Pellets were resuspended in a hypotonic solution of 10 mM HEPES, 15 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT and the protease inhibitors PMSF, leupeptin and pepstatin and placed on ice for 10 min. Cells were disrupted by using a dounce homogenizer (Radnoti) until microscopic analysis showed 495% free nuclei or disrupted cells. The nuclei were pelleted by centrifugation at 8006g for 5 min; the supernatant was mixed with a 2X Laemmli buffer and saved as the cytoplasmic fraction. The pellet was resuspended in the hypotonic solution and NP-40 (Sigma) was added to a final concentration of 0.1%. This was vortexed and pelleted as before. The supernatant was removed and the pellet was solubilized in Laemmli buffer.
ELISA
Lysates from A1-a transfected and mock vector transfected COS-7 cells were dissolved in 2 ± 4 volumes of guanidinium HCl and diluted in ELISA Coating Buffer (0.1 M NaHCO 3 in PBS, pH 8.2) to a final concentration of 10 mg/ml. ELISA plate wells were coated with 100 ml of this solution and incubated at 48C overnight. The wells were washed three times with washing buffer (0.05% Tween-20 in PBS) and then coated with 200 ml of 3% BSA (Sigma) in PBS and incubated at 48C overnight. The wells were then washed twice as before and then 100 ml of either rat serum or hybridoma supernatant was added and incubated at 378C for 1 h. After two more rounds of washing, 100 ml of a goat anti-rat antibody conjugated to HRP (Santa Cruz) was added at 1 : 1000 dilution to each well and incubated at 378C for 1 h. Each well was then washed four times and 50 ml of TMB solution (1 mg TMB (Sigma) dissolved in 1 ml DMSO plus 9 ml 0.1 M sodium acetate pH 6 and 3.3 ml of H 2 O 2 ) were added to each well. Wells were incubated at room temperature for 30 min under cover and then 50 ml of 1 M H 2 SO 4 was added to stop the reaction. A1-a positive sera or supernatants were determined by measuring absorbance at 450 nm.
Western blot analysis
COS-7 cell lysates were analyzed for protein by the Bradford assay (Bio-Rad). Samples were separated on 15% SDS ± PAGE gels and transferred to Immobilon-P membranes (Millipore) by wet electrophoresis transfer (Bio-Rad) in 25 mM Tris, 190 mM glycine for 40 min at 100 V. The membranes were blocked with 5% dry milk in PBS (block solution) and probed with monoclonal antibody 20.5 hybridoma supernatant or anti-Cytochrome c monoclonal antibody (Pharmingen) at 1 : 1000 dilution overnight at 48C. The blot was then washed three times in PBS containing 0.5% Tween-20 for 15 min per wash, blocked again for 20 min, incubated with either goat anti-rat or goat anti-mouse antibody conjugated to HRP (Santa Cruz) at 1 : 2000 and 
Extraction of COS-7 cell nuclei
Nuclease facilitated extraction was performed as described before. 56 Briefly, COS-7 nuclei were resuspended in 0.1 mM MgCl 2 and diluted fivefold with 4 volumes of 10% (w/v) sucrose, 10 mM TEA-HCl (pH 8.5), 0.1 mM MgCl 2 , 0.5 mM PMSF and 1 mM DTT. Five mg of DNAse I and 1 mg RNAse A were added per milliliter, and the sample was incubated for 15 min at room temperature. After underlayering with one volume of ice cold 30% sucrose, 10 mM TEA-HCl (pH 7.4), 1 mM MgCl 2 , 0.5 mM PMSF and 1 mM DTT, the sample was pelleted by centrifugation at 20 0006g. The supernatant was collected and the pellet resuspended by vortexing in 10% sucrose, 10 mM TEA-HCl (pH 7.4), 0.1 mM MgCl 2 , 0.5 mM PMSF and 1 mM DTT. Twenty-five mg of DNAse I and 5 mg of RNAse A were then added per milliliter. The sample was incubated and pelleted as before except that the underlayering solution was 30% sucrose, 10 mM TEA-HCl (pH 7.4), 5 mM MgCl 2 0.5 mM PMSF and 1 mM DTT. The supernatant was collected and the pellet resuspended in a Laemmli buffer.
Sequential extraction of A1-a transfected COS-7 cell nuclei was performed in the following manner. The nuclear pellet, produced from homogenization and hypotonic washing, was resuspended in 1 ml of a 1% Triton-X100 solution, vortexed vigorously and then pelleted by centrifugation for 10 min at 48C. The supernatant was collected and the pellet washed in a further 1 ml of 1% Triton-X100. The suspension was vortexed, pelleted and collected as before. The pellet was then washed sequentially with 1 ml solutions of the following: 0.15 M NaCl placed on ice for 5 min, 0.25 M HCl placed on ice for 5 min, 0.5 M Tris pH 7.4, 6 M urea and finally a Laemmli buffer containing 2% SDS. Supernatants from each wash were stored at 7208C. For Western blot analysis, 15 ml of each supernatant was mixed with 15 ml of a 2X SDS Laemmli buffer, boiled for 5 min and then loaded on a gel for analysis. 15 ml of the SDS Laemmli buffer containing the final pellet was used undiluted.
Immuno¯uorescent microscopy
COS-7 cells seeded in chamber slides were harvested as described above and permeabilized in 0.2% Triton-X100 in PBS for 15 min. Cells were rinsed in PBS three times and then blocked in PBS containing 0.05% Triton-X100, 2% BSA and 1% goat serum for 30 min. The cells were then probed with anti-A1-a monoclonal antibody 20.5 culture supernatant undiluted or anti-Bcl-2 monoclonal clone 4D7 at 1 : 100 (Pharmingen) for 3 h. Cells were washed three times with 0.05% Triton-X100 in PBS for 15 min per wash. Cells were blocked again for another 30 min and then probed with either FITC-goat anti-rat IgG or FITC-goat anti-rabbit IgG (Santa Cruz) for 1 h. The cells were then washed several times in 0.05% Triton-X100 in PBS for 3 min per wash. Following a further wash in PBS, cells were counterstained for actin with Texas-Red phalloidin (Molecular Probes) for 1.5 h according to the manufacturer's protocol. The cells were washed three times in PBS for 5 min per wash and then mounted using the ProLong Antifade kit (Molecular Probes). When TUNEL staining was performed, it was done prior to probing with the A1-a monoclonal antibody. TUNEL staining assay was performed as per manufacturer's protocol (Boehringer Mannheim). Slides were examined by confocal microscopy. Images were captured using both phase and fluorescent microscopy including both FITC and Texas-Red filters. Images from each filter were overlaid to form the composite figure or presented separately as in Figure 6C .
HPLC
The nuclear fraction of A1-a transfected COS-7 cells was subjected to the sequential extraction protocol described above. 250 ml of the final extract in Laemmli buffer containing 2% SDS was removed and 1 ml of cold acetone was added. This was vortexed and stored overnight at 7208C. The resulting precipitate was pelleted by centrifugation at 16 0006g at 48C for 15 min. The supernatant was removed and the pellet was washed with 1 ml of cold acetone overnight followed by centrifugation. The pellet was quickly dried using vacuum centrifugation and then dissolved in 6 M urea. A1-a in 6 M urea was loaded onto a Vydac protein C4 reversed-phase column (25064.6 mm, Vydac). The gel was equilibrated with 0.1% (v/v) trifluoroacetic acid in 90% water and 10% acetonitrile. A1-a was eluted with a two-step linear gradient to 80% acetonitrile in 1% aqueous trifluoroacetic acid at a flow rate of 1 ml/min.
